Multimodality treatment concepts for metastatic breast cancer;Multimodale Therapiekonzepte beim metastasierten Mammakarzinom

Internist

Volumn 51, Issue 11, 2010, Pages 1358-1365

  Heinemann, V ^a   Kahlert, S ^a   Stemmler, H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Breast cancer; Hepatic resection; Liver metastasis; Oligometastasis; Radiation

Indexed keywords

ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; MULTIMODALITY CANCER THERAPY; RETROSPECTIVE STUDY; SURVIVAL TIME;

BONE NEOPLASMS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 78650367798     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-010-2676-4     Document Type: Article

References (30)

1. Adam R, Chiche L, Aloia T et al (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1452 patients and development of a prognostic model. Ann Surg 244:524-535
2. Allgaier HP, Deibert P, Zuber I, Blum HE (1998) Perkutane Behandlung von Lebertumoren durch interstitielle Radio-Frequenz-Thermoablation. Dtsch Med Wochenschr 123:907-911
3. Atalay G, Biganzoli L, Renard F et al (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomized metastatic breast cancer trials. Eur J Cancer 39:2439-2449
4. Camacho LH, Kurzrock R, Cheung A (2007) Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer 109:2190-2196
5. Chia SK, Speers CH, D'yachkiva Y et al (2007) The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 110:973-979
6. Coldwell DM, Kennedy AS, Nutting CW (2007) Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 69:800-804
7. Diamond JR, Finlayson CA, Borges VF (2009) Hepatic complications of breast cancer. Lancet Oncol 10:615-621
8. Elias D, Maisonnette F, Druet-Cabanac M et al (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185:158-164
9. Giordano SH, Buzdar AU, Smith TL et al (2004) Is breast cancer survival improving? Cancer 100:44-52
10. Harris JR (Hrsg) (2000) Diseases of the breast, 2. edn. Lippincott Williams & Wilkins, Philadelphia, p 907
11. Jardines L, Callans LS, Torosian MH (1993) Recurrent breast cancer: presentation, diagnosis and treatment. Semin Oncol 20:538-547
12. Kennecke H, Yerushalmi R, Woods R et al (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28:3271-3277
13. Lermite E, Marzano E, Chereau E et al (2009) Surgical resection of liver metastases from breast cancer. Surg Oncol 1-6
14. Livraghi T, Goldberg SN, Solbiati L et al (2001) Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 220:145-149
15. Mack MG, Straub R, Eichler K et al (2004) Breast cancer metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 233:400-409 (Pubitemid 39423798)
16. Martinez SR, Young SE, Giuliono AE et al (2006) The utility of estrogen receptor, progesterone receptor, and HER-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. Am J Surg 191:281-283
17. Pagani O, Senkus E, Wood W et al (2010) International guidelines for management of metastatic breast cancer: Can metastatic breast cancer be cured? J Natl Cancer Inst 102:456-463
18. Pentheroudakis G, Fountzilas G, Bafaloukos D et al (2005) Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Res Treat 97:237-244
19. Pocard M, Pouillart P, Asselain B et al (2000) Hepatic resection for breast cancer metastases: results and prognostic factors. Eur J Surg Oncol 26:155-159
20. Popperl G, Helmberger T, Munzing W et al (2005) Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors. Cancer Biother Radiopharm 20:200-208
21. Raab R, Nussbaum KT, Behrend M, Weimann A (1998) Liver metastases of breast cancer: results of liver resection. Anticancer Res 18:2231-2233
22. Ryberg M, Nielsen D, Osterlind K et al (2001) Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy. Ann Oncol 12:81-87
23. Schneebaum S, Walker MJ, Young D et al (1994) The regional treatment of liver metastases from breast cancer. J Surg Oncol 55:26-31
24. Selzner M, Morse MA, Vredenburgh JJ et al (2000) Liver metastases from breast cancer: long-term survival after curative resection. Surgery 127:383-389
25. Shibata T, Niinobu T, Ogata N et al (2000) Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89:276-284
26. Singletary SE, Walsh G, Vauthey J-N et al (2003) A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8:241-251
27. Tait CR, Waterworth A, Loncaster J et al (2005) The oligometastatic state in breast cancer: hypothesis or reality. Breast 14:87-93
28. Tomiak E, Piccart M, Mignolet et al (1996) Characterization of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study. Eur J Cancer 32 A: 1876-1887
29. Vogl TJ, Muller PK, Mack MG et al (1999) Liver metastases; interventional therapeutic techniques and results, state of the art. Eur Radiol 9:675-684
30. Wyld L, Gutteridge E, Pinder SE et al (2003) Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 89:284-290